Hymenorrhea. Excessive and frequent menstruation with regular cycle
Conditions
Interventions
Intervention 1: There are two intervention groups in the study group. The serum of Barragon syrup is given at 5 cc every 8 hours in the first 5 days of menstruation. In the other group, the muscle cap
Treatment - Drugs
Placebo
There are two intervention groups in the study group. The serum of Barragon syrup is given at 5 cc every 8 hours in the first 5 days of menstruation. In the other group, the muscle capsule is given ev
Placebo group Placebo syrup 5 cc every 8 hours with Mefenamic acid capsule is given one every 8 hours.
Sponsors
Deputy of Research and Technology of Mashhad University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
36 Years to 45 Years
Inclusion criteria
Inclusion criteria: Criteria for entering the study of outpatients between the ages of 36-45 years with a complaint of hypernorrhoea that have negative pregnancy tests and not being breast-fed;The patient has no desire for hormonal treatment (ocp);Genic examination is normal;Pap smear sample of the patient is healthy;At the same time as hormonal treatments,Not use to other Herbal remedies and herbs; A month before entering in to the study,Doesn't use any drug to heal much hemorrhage;Use non-hormonal prevention;Hb is between 11 and 14;A patient with diabetes,Does not have uncontrolled blood pressure, congestive heart disease, and blood dislocations;The patient has no history of chronic diseases such as lupus and thyroid problems;The patient does not have a history of uterine malformations, ovaries, or other malignancies;Patient does not have hyperlichotheneemia ;Does not have IUD;The BMI is between 18/5 and 30;No fibroma.Exit criteria for patients who get pregnant during the study;Patients who use hormonal drugs during the study;Patients with possible side effects;Patients who require other interventions and have surgery;Patients who decide to leave the study with a personal request;The bleeding during the study is so severe that it requires emergency procedures.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity and duration of menstrual bleeding. Timepoint: Beginning of the study and after three periods. Method of measurement: PBAC chart. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMozhdeh Khodabakhsh
School of Traditional Medicine and Mashhad Supplement
Outcome results
None listed